Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report

X-linked agammaglobulinemia (XLA) is a hereditary immune disorder that predisposes patients to frequent and severe bacterial infections caused by encapsulated bacteria (such as Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae). Otitis media, sinusitis, and pneumonia are common complications of XLA that require prompt diagnosis and treatment. Cytomegaloviruses (CMV) cause widespread and severe infections in immunocompromised individuals, affecting the respiratory tract, and consequently, leading to pneumonia, which is associated with a high mortality rate. However, CMV-induced pneumonia is rarely reported in patients with XLA. This case study details a 37-year-old male patient with XLA presenting with fever, productive cough, and dyspnea. The patient was diagnosed with CMV pneumonia and recovered after treatment. To the best of our knowledge, this is the first reported case of CMV pneumonia in a patient with XLA in Taiwan. This case study emphasizes that CMV pneumonia in patients with XLA is a treatable condition if diagnosed promptly, and that a shorter duration of treatment with the antiviral agent, in combination with immunoglobulin replacement therapy, can resolve symptoms.

[1]  Mark J. Ponsford,et al.  Increased Respiratory Viral Detection and Symptom Burden Among Patients with Primary Antibody Deficiency: Results from the BIPAD Study , 2020, The Journal of Allergy and Clinical Immunology: In Practice.

[2]  A. Coscia,et al.  Where do we Stand after Decades of Studying Human Cytomegalovirus? , 2020, Microorganisms.

[3]  Michael Saindon,et al.  X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia , 2020, Cureus.

[4]  Zhen Wang,et al.  Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies☆ , 2019, The World Allergy Organization journal.

[5]  A. Humar,et al.  Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[6]  H. Abdullah,et al.  Human cytomegalovirus pneumonia in an immunocompetent patient: a very uncommon but treatable condition , 2019, BMJ Case Reports.

[7]  A. Plebani,et al.  X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world , 2019, The World Allergy Organization journal.

[8]  W. Britt,et al.  New therapies for human cytomegalovirus infections. , 2018, Antiviral research.

[9]  W. Leisenring,et al.  Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia , 2017, The Journal of infectious diseases.

[10]  K. Kagan,et al.  Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  L. Torres-Miñana,et al.  CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation , 2017, Bone Marrow Transplantation.

[12]  T. Harrer,et al.  Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies , 2016, Clinical and experimental immunology.

[13]  V. Miller,et al.  Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  H. Yamada,et al.  Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells. , 2017, Viral immunology.

[15]  Rongchang Chen,et al.  Bruton's agammaglobulinemia in an adult male due to a novel mutation: a case report. , 2016, Journal of thoracic disease.

[16]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[17]  D. Manson,et al.  Atypical presentation and manifestations in X-linked agammaglobulinemia patients with novel BTK mutations , 2015 .

[18]  V. Lougaris,et al.  Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. , 2014, The Journal of allergy and clinical immunology.

[19]  M. Ballow.  Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  H. Chen,et al.  Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient , 2013, BMC Pediatrics.

[21]  H. Jin,et al.  Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells , 2013, Journal of Virology.

[22]  O. Ruuskanen,et al.  Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia , 2010, Journal of Allergy and Clinical Immunology.

[23]  H. Einsele,et al.  Management of CMV infections: recommendations from the infectious diseases working party of the EBMT , 2004, Bone Marrow Transplantation.

[24]  D. Granoff,et al.  A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. , 2001, Jornal de Pediatria.

[25]  D. Nelson,et al.  A case of X-linked agammaglobulinemia diagnosed in adulthood. , 2001, Clinical immunology.

[26]  O. Ruuskanen,et al.  Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. , 1999, American journal of respiratory and critical care medicine.

[27]  G. Litman,et al.  X-linked agammaglobulinemia presenting as transient hypogammaglobulinemia of infancy. , 1995, The Journal of allergy and clinical immunology.